Another round-up of the latest genomics news and research from the past week – enjoy!
Top stories from the past week
- An international team of scientists has sequenced the genome of a capuchin monkey, revealing new genetic clues about the evolution of their long lifespan and large brains. (Orkin et al, 2021)
- News findings reveal how the tumour microenvironment can subvert the immune system and enable cancer to evade attack, providing new ways to boost immunotherapy. (Delgoffe et al, 2021)
- Using an avian model, researchers have discovered that ciliopathic micrognathia results from abnormal skeletal differentiation and remodelling. (Brugmann et al, 2021)
- New research highlights the polygenic contributions to attainment in English, Maths and Science during adolescence. (Meaburn et al, 2021)
- Using several techniques, researchers have, for the first time, been able to track osmium in a single cancer cell, enabling them to see how single cells react to cancer treatment. (Sadler et al, 2021)
- According to new research, almost one in five has a mutation that provides super resilience to the cold. (Westerblad et al, 2021)
- Scientists have successfully created mini-bile ducts in the lab and shown that these can be used to repair damaged human livers. (Sampaziotis et al, 2021)
In other news
- Researchers from Dana-Farber Cancer Institute, the FDA and the AACR have released recommendations designed to address the underrepresentation of African Americans in clinical trials for multiple myeloma. (Anderson et al, 2021)
- Join us for the final instalment in our latest three-part webinar series – ‘Microbiome Sequencing ONLINE‘ . In this series, we explore how metagenomics and microbiome sequencing is uncovering the hidden traits of the invisible world. The final webinar is taking place on Thursday 25th February 3PM GMT/4PM CET/10AM EST. Register now.
- Download our latest report: ‘Liquid Biopsy: Current Status and Future Directions’. This report will provide you with an overview of liquid biopsy technologies, exclusive interviews with key leaders in the field and insights into the current technical and social barriers impacting clinical uptake. Get your free copy here.